Compare CRCT & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRCT | CVAC |
|---|---|---|
| Founded | 1969 | 2000 |
| Country | United States | Germany |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.2B |
| IPO Year | 2021 | 2020 |
| Metric | CRCT | CVAC |
|---|---|---|
| Price | $5.08 | $5.12 |
| Analyst Decision | Strong Sell | Hold |
| Analyst Count | 3 | 3 |
| Target Price | $4.18 | ★ $6.83 |
| AVG Volume (30 Days) | 602.3K | ★ 1.7M |
| Earning Date | 11-04-2025 | 11-24-2025 |
| Dividend Yield | ★ 18.76% | N/A |
| EPS Growth | 27.98 | ★ 94.02 |
| EPS | 0.37 | ★ 0.94 |
| Revenue | ★ $714,492,000.00 | $83,000,117.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $23.40 |
| P/E Ratio | $13.70 | ★ $5.50 |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.94 | $2.48 |
| 52 Week High | $7.33 | $5.72 |
| Indicator | CRCT | CVAC |
|---|---|---|
| Relative Strength Index (RSI) | 56.38 | 42.38 |
| Support Level | $4.65 | $5.11 |
| Resistance Level | $4.90 | $5.23 |
| Average True Range (ATR) | 0.14 | 0.13 |
| MACD | 0.07 | -0.01 |
| Stochastic Oscillator | 100.00 | 29.17 |
Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.